An ACE inhibitor and active metabolite of perindopril
Related Products
Pro-drug Form(s)
20796Perindopril
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Perindoprilat

Item No. 17574

Technical Information
Formal Name
(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-carboxybutyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic acid
CAS Number
95153-31-4
Synonyms
  • S-9780
Molecular Formula
C17H28N2O5
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: 30 mg/mlDMSO: 30 mg/mlPBS (pH 7.2): 10 mg/ml
SMILES
[H][C@]12[C@](N(C([C@H](C)N[C@@H](CCC)C(O)=O)=O)[C@H](C(O)=O)C2)([H])CCCC1
InChi Code
InChI=1S/C17H28N2O5/c1-3-6-12(16(21)22)18-10(2)15(20)19-13-8-5-4-7-11(13)9-14(19)17(23)24/h10-14,18H,3-9H2,1-2H3,(H,21,22)(H,23,24)/t10-,11-,12-,13-,14-/m0/s1
InChi Key
ODAIHABQVKJNIY-PEDHHIEDSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Perindoprilat is an inhibitor of angiotensin-converting enzyme (ACE; IC50 = 1.05 nM) and an active metabolite of the ACE inhibitor prodrug perindopril (Item No. 20796).1 It reduces expression of the mRNA encoding VEGF in KB oral squamous cell carcinoma cells when used at concentrations of 1 and 2 µM.2 Perindoprilat, in combination with bradykinin, induces endothelium-dependent relaxation in isolated dog basilar and coronary arteries with 30% maximum induction (IC30) values of 0.46 and 1.15 µM, respectively.3 In vivo, perindoprilat (20 µg/kg) reverses or prevents restricted oxygen-induced decreases in mean blood pressure, renal blood flow, and renal vascular resistance, as well as increases in the urine flow rate in an acute hypoxemia-induced rabbit model of renal hypoperfusion.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ceconi, C., Francolini, G., Olivares, A., et alAngiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. Eur. J. Pharmacol. 577(1-3), 1-6 (2007).

    2. Yasumatsu, R., Nakashima, T., Masuda, M., et alEffects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells. J. Cancer Res. Clin. Oncol. 130(10), 567-573 (2004).

    3. Kerth, P.A., and Vanhoutte, P.M. Effects of perindoprilat on endothelium-dependent relaxations and contractions in isolated blood vessels. Am. J. Hypertens. 4(3 Pt 2), 226S-234S (1991).

    4. Huet, R., Gouyon, J.-B., and Guignard, J.-P. Prevention of hypoxemia-induced renal dysfunction by perindoprilat in the rabbit. Life Sci. 61(22), 2157-2165 (1997).